MTDH and cancer: Clinically, it was further suggested that enhanced expression of AEG-1 is a marker of poor prognosis in cancer patients, emphasizing the scenario that understanding how the amount of protein expression regulated might be the most valuable factor to target tumorigenesis due to AEG-1 overload.